FIELD: medicine, pharmacy. SUBSTANCE: invention proposes the use of saturated mono- or bicyclic terpene alcohols, ethers, ketones or thiols for inhibition of release of arachidonic acid from phospholipide storage of human cells or for inhibition of release and synthesis of mediators of inflammation and cytokines from human cells. Invention proposes active components of drugs with indicated properties. Invention reveals the novel mechanism of effect of the known in medicine terpenes, for example, menthol, terpenethiol, carone, camphor, borneol, carane, pinane, bornane. EFFECT: new mechanism of terpene effect. 6 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
COMBINATION OF R,R-GLYCOPYRROLATE AND MONTELUKAST FOR TREATMENT OF RESPIRATORY DISEASES AND BASED ON IT PHARMACEUTICAL COMPOSITION | 2006 |
|
RU2420285C2 |
COMBINATION AND PHARMACEUTICAL PREPARATION FOR TREATMENT OF INFLAMMATORY DISEASES | 2006 |
|
RU2465915C2 |
THERAPEUTIC USE OF EKTOIN | 2012 |
|
RU2648475C2 |
USE OF A DERIVATIVE GLUTARIMIDE TO OVERCOME RESISTANCE TO STEROIDS AND THERAPY OF DISEASES ASSOCIATED WITH ABERRANT SIGNALING OF INTERFERON GAMMA | 2018 |
|
RU2712281C1 |
COMPOSITION CONTAINING Actinidia AND METHODS OF THEIR APPLICATION | 2006 |
|
RU2423139C2 |
ANTIBODIES TO CD6 FOR THE TREATMENT OF SEVERE ASTHMA | 2019 |
|
RU2796586C2 |
METHOD OF OPTIMISATION TREATMENT OF BRONCHIAL ASTHMA | 2009 |
|
RU2403073C1 |
AGENT FOR PROPHYLAXIS AND/OR TREATMENT OF PATIENTS WITH DISEASES ACCOMPANYING THE EXCESSIVE SYNTHESIS OF LEUKOTRIENES AND/OR PROSTAGLANDINS | 1992 |
|
RU2121832C1 |
ANTIALLERGIC AGENT | 2006 |
|
RU2324491C1 |
AGENT FOR COPING WITH STEROID RESISTANCE | 2009 |
|
RU2404792C1 |
Authors
Dates
2001-01-10—Published
1994-06-11—Filed